Jun-yi Xu

Rethinking sympathetic regulation in cancer: From uniform signaling to context-dependent precision targeting

Accumulating evidence has established the sympathetic nervous system (SNS) as a critical regulator of tumor progression, making adrenergic signaling an attractive therapeutic target in oncology. Consequently, β-adrenergic blockade has been widely investigated as a strategy to inh...